APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lipid Nanoparticle (LNP) Services Market Analysis and Forecast 2026-2032

15 January 2026211 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Services Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Services Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Services Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Services Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle (LNP) Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lipid Nanoparticle (LNP) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lipid Nanoparticle (LNP) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lipid Nanoparticle (LNP) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lipid Nanoparticle (LNP) Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lipid Nanoparticle (LNP) Services include PreciGenome, Creative Biolabs, Genscript, ReciBioPharm, CD Bioparticles, Vernal Biosciences, Hzymes Biotech, LipExoGen and Evonik, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lipid Nanoparticle (LNP) Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lipid Nanoparticle (LNP) Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Nanoparticle (LNP) Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lipid Nanoparticle (LNP) Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lipid Nanoparticle (LNP) Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lipid Nanoparticle (LNP) Services revenue, projected growth trends, production technology, application and end-user industry.

Lipid Nanoparticle (LNP) Services Segment by Company

PreciGenome

Creative Biolabs

Genscript

ReciBioPharm

CD Bioparticles

Vernal Biosciences

Hzymes Biotech

LipExoGen

Evonik

Merck

Cayman

Echelon

WuXi STA

BOC Sciences

Carcell

Cambridge Bioscience

FluidicLab

Guangzhou Anernor Biotechnology

Nanjing Yasmin Biotechnology

vectorbuilder

Helix Biotech

FUJIFILM Holdings

Ascendia Pharmaceuticals

Catalent

Polymun Scientific

Wacker

Corden Pharma

Cytiva

Croda International

Nippon Fine Chemical

Patheon

Lonza

Lipid Nanoparticle (LNP) Services Segment by Type

Formulation Service

Development Service

Others

Lipid Nanoparticle (LNP) Services Segment by Application

Drug Delivery

Diagnostics

Gene Therapy

Others

Lipid Nanoparticle (LNP) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lipid Nanoparticle (LNP) Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lipid Nanoparticle (LNP) Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Nanoparticle (LNP) Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Formulation Service Major Player Table 3. Development Service Major Player Table 4. Others Major Player Table 5. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Delivery Major Player Table 7. Diagnostics Major Player Table 8. Gene Therapy Major Player Table 9. Others Major Player Table 10. Lipid Nanoparticle (LNP) Services Industry Trends Table 11. Lipid Nanoparticle (LNP) Services Industry Drivers Table 12. Lipid Nanoparticle (LNP) Services Industry Opportunities and Challenges Table 13. Lipid Nanoparticle (LNP) Services Industry Restraints Table 14. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2021-2026) Table 17. Global Lipid Nanoparticle (LNP) Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Lipid Nanoparticle (LNP) Services Market Share by Region (2027-2032) Table 19. Global Lipid Nanoparticle (LNP) Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Players (2021-2026) Table 21. Global Lipid Nanoparticle (LNP) Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Lipid Nanoparticle (LNP) Services Key Players Headquarters & Area Served Table 23. Global Lipid Nanoparticle (LNP) Services Players, Product Type & Application Table 24. Global Lipid Nanoparticle (LNP) Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Lipid Nanoparticle (LNP) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Lipid Nanoparticle (LNP) Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2021-2026) Table 31. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2027-2032) Table 32. Global Lipid Nanoparticle (LNP) Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021-2026) Table 36. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2027-2032) Table 37. PreciGenome Company Information Table 38. PreciGenome Business Overview Table 39. PreciGenome Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio Table 41. PreciGenome Recent Development Table 42. Creative Biolabs Company Information Table 43. Creative Biolabs Business Overview Table 44. Creative Biolabs Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio Table 46. Creative Biolabs Recent Development Table 47. Genscript Company Information Table 48. Genscript Business Overview Table 49. Genscript Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Genscript Lipid Nanoparticle (LNP) Services Product Portfolio Table 51. Genscript Recent Development Table 52. ReciBioPharm Company Information Table 53. ReciBioPharm Business Overview Table 54. ReciBioPharm Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio Table 56. ReciBioPharm Recent Development Table 57. CD Bioparticles Company Information Table 58. CD Bioparticles Business Overview Table 59. CD Bioparticles Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio Table 61. CD Bioparticles Recent Development Table 62. Vernal Biosciences Company Information Table 63. Vernal Biosciences Business Overview Table 64. Vernal Biosciences Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 66. Vernal Biosciences Recent Development Table 67. Hzymes Biotech Company Information Table 68. Hzymes Biotech Business Overview Table 69. Hzymes Biotech Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 71. Hzymes Biotech Recent Development Table 72. LipExoGen Company Information Table 73. LipExoGen Business Overview Table 74. LipExoGen Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio Table 76. LipExoGen Recent Development Table 77. Evonik Company Information Table 78. Evonik Business Overview Table 79. Evonik Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Evonik Lipid Nanoparticle (LNP) Services Product Portfolio Table 81. Evonik Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Merck Lipid Nanoparticle (LNP) Services Product Portfolio Table 86. Merck Recent Development Table 87. Cayman Company Information Table 88. Cayman Business Overview Table 89. Cayman Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Cayman Lipid Nanoparticle (LNP) Services Product Portfolio Table 91. Cayman Recent Development Table 92. Echelon Company Information Table 93. Echelon Business Overview Table 94. Echelon Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Echelon Lipid Nanoparticle (LNP) Services Product Portfolio Table 96. Echelon Recent Development Table 97. WuXi STA Company Information Table 98. WuXi STA Business Overview Table 99. WuXi STA Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio Table 101. WuXi STA Recent Development Table 102. BOC Sciences Company Information Table 103. BOC Sciences Business Overview Table 104. BOC Sciences Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio Table 106. BOC Sciences Recent Development Table 107. Carcell Company Information Table 108. Carcell Business Overview Table 109. Carcell Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Carcell Lipid Nanoparticle (LNP) Services Product Portfolio Table 111. Carcell Recent Development Table 112. Cambridge Bioscience Company Information Table 113. Cambridge Bioscience Business Overview Table 114. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio Table 116. Cambridge Bioscience Recent Development Table 117. FluidicLab Company Information Table 118. FluidicLab Business Overview Table 119. FluidicLab Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio Table 121. FluidicLab Recent Development Table 122. Guangzhou Anernor Biotechnology Company Information Table 123. Guangzhou Anernor Biotechnology Business Overview Table 124. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 126. Guangzhou Anernor Biotechnology Recent Development Table 127. Nanjing Yasmin Biotechnology Company Information Table 128. Nanjing Yasmin Biotechnology Business Overview Table 129. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio Table 131. Nanjing Yasmin Biotechnology Recent Development Table 132. vectorbuilder Company Information Table 133. vectorbuilder Business Overview Table 134. vectorbuilder Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio Table 136. vectorbuilder Recent Development Table 137. Helix Biotech Company Information Table 138. Helix Biotech Business Overview Table 139. Helix Biotech Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio Table 141. Helix Biotech Recent Development Table 142. FUJIFILM Holdings Company Information Table 143. FUJIFILM Holdings Business Overview Table 144. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio Table 146. FUJIFILM Holdings Recent Development Table 147. Ascendia Pharmaceuticals Company Information Table 148. Ascendia Pharmaceuticals Business Overview Table 149. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio Table 151. Ascendia Pharmaceuticals Recent Development Table 152. Catalent Company Information Table 153. Catalent Business Overview Table 154. Catalent Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Catalent Lipid Nanoparticle (LNP) Services Product Portfolio Table 156. Catalent Recent Development Table 157. Polymun Scientific Company Information Table 158. Polymun Scientific Business Overview Table 159. Polymun Scientific Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio Table 161. Polymun Scientific Recent Development Table 162. Wacker Company Information Table 163. Wacker Business Overview Table 164. Wacker Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Wacker Lipid Nanoparticle (LNP) Services Product Portfolio Table 166. Wacker Recent Development Table 167. Corden Pharma Company Information Table 168. Corden Pharma Business Overview Table 169. Corden Pharma Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio Table 171. Corden Pharma Recent Development Table 172. Cytiva Company Information Table 173. Cytiva Business Overview Table 174. Cytiva Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio Table 176. Cytiva Recent Development Table 177. Croda International Company Information Table 178. Croda International Business Overview Table 179. Croda International Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Croda International Lipid Nanoparticle (LNP) Services Product Portfolio Table 181. Croda International Recent Development Table 182. Nippon Fine Chemical Company Information Table 183. Nippon Fine Chemical Business Overview Table 184. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio Table 186. Nippon Fine Chemical Recent Development Table 187. Patheon Company Information Table 188. Patheon Business Overview Table 189. Patheon Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Patheon Lipid Nanoparticle (LNP) Services Product Portfolio Table 191. Patheon Recent Development Table 192. Lonza Company Information Table 193. Lonza Business Overview Table 194. Lonza Lipid Nanoparticle (LNP) Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Lonza Lipid Nanoparticle (LNP) Services Product Portfolio Table 196. Lonza Recent Development Table 197. North America Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 198. North America Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 199. North America Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 200. North America Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 201. North America Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. North America Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026) & (US$ Million) Table 203. North America Lipid Nanoparticle (LNP) Services Revenue by Country (US$ Million) & (2027-2032) Table 204. Europe Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 205. Europe Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 206. Europe Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Europe Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026) & (US$ Million) Table 210. Europe Lipid Nanoparticle (LNP) Services Revenue by Country (US$ Million) & (2027-2032) Table 211. China Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 212. China Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 213. China Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 214. China Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 216. Asia Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 217. Asia Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 218. Asia Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 219. Asia Lipid Nanoparticle (LNP) Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Lipid Nanoparticle (LNP) Services Revenue by Region (US$ Million) & (2021-2026) Table 221. Asia Lipid Nanoparticle (LNP) Services Revenue by Region (US$ Million) & (2027-2032) Table 222. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026) & (US$ Million) Table 228. SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (US$ Million) & (2027-2032) Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Lipid Nanoparticle (LNP) Services Image Figure 2. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Nanoparticle (LNP) Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Formulation Service Image Figure 5. Development Service Image Figure 6. Others Image Figure 7. Global Lipid Nanoparticle (LNP) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lipid Nanoparticle (LNP) Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Delivery Image Figure 10. Diagnostics Image Figure 11. Gene Therapy Image Figure 12. Others Image Figure 13. Global Lipid Nanoparticle (LNP) Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Lipid Nanoparticle (LNP) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Lipid Nanoparticle (LNP) Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Lipid Nanoparticle (LNP) Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lipid Nanoparticle (LNP) Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lipid Nanoparticle (LNP) Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2021-2032) Figure 21. Global Lipid Nanoparticle (LNP) Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021-2032) Figure 24. North America Lipid Nanoparticle (LNP) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032) Figure 26. North America Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032) Figure 27. North America Lipid Nanoparticle (LNP) Services Revenue Share by Country (2021-2032) Figure 28. United States Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Lipid Nanoparticle (LNP) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032) Figure 33. Europe Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032) Figure 34. Europe Lipid Nanoparticle (LNP) Services Revenue Share by Country (2021-2032) Figure 35. Germany Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Lipid Nanoparticle (LNP) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032) Figure 45. China Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032) Figure 46. Asia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032) Figure 48. Asia Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032) Figure 49. Asia Lipid Nanoparticle (LNP) Services Revenue Share by Region (2021-2032) Figure 50. Japan Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Lipid Nanoparticle (LNP) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Lipid Nanoparticle (LNP) Services Revenue Share by Country (2021-2032) Figure 60. Brazil Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Lipid Nanoparticle (LNP) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Formulation Service
  • Development Service
  • Others
Applications
  • Drug Delivery
  • Diagnostics
  • Gene Therapy
  • Others
Companies covered
  • PreciGenome
  • Creative Biolabs
  • Genscript
  • ReciBioPharm
  • CD Bioparticles
  • Vernal Biosciences
  • Hzymes Biotech
  • LipExoGen
  • Evonik
  • Merck
  • Cayman
  • Echelon
  • WuXi STA
  • BOC Sciences
  • Carcell
  • Cambridge Bioscience
  • FluidicLab
  • Guangzhou Anernor Biotechnology
  • Nanjing Yasmin Biotechnology
  • vectorbuilder
  • Helix Biotech
  • FUJIFILM Holdings
  • Ascendia Pharmaceuticals
  • Catalent
  • Polymun Scientific
  • Wacker
  • Corden Pharma
  • Cytiva
  • Croda International
  • Nippon Fine Chemical
  • Patheon
  • Lonza

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lipid Nanoparticle (LNP) Services Market by Type
  3. 1.2.1 Global Lipid Nanoparticle (LNP) Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Formulation Service
  5. 1.2.3 Development Service
  6. 1.2.4 Others
  7. 1.3 Lipid Nanoparticle (LNP) Services Market by Application
  8. 1.3.1 Global Lipid Nanoparticle (LNP) Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Delivery
  10. 1.3.3 Diagnostics
  11. 1.3.4 Gene Therapy
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Lipid Nanoparticle (LNP) Services Market Dynamics
  1. 2.1 Lipid Nanoparticle (LNP) Services Industry Trends
  2. 2.2 Lipid Nanoparticle (LNP) Services Industry Drivers
  3. 2.3 Lipid Nanoparticle (LNP) Services Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticle (LNP) Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lipid Nanoparticle (LNP) Services Market Perspective (2021-2032)
  2. 3.2 Global Lipid Nanoparticle (LNP) Services Growth Trends by Region
  3. 3.2.1 Global Lipid Nanoparticle (LNP) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lipid Nanoparticle (LNP) Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Lipid Nanoparticle (LNP) Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lipid Nanoparticle (LNP) Services Revenue by Players
  2. 4.1.1 Global Lipid Nanoparticle (LNP) Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lipid Nanoparticle (LNP) Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lipid Nanoparticle (LNP) Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lipid Nanoparticle (LNP) Services Key Players Headquarters & Area Served
  7. 4.4 Global Lipid Nanoparticle (LNP) Services Players, Product Type & Application
  8. 4.5 Global Lipid Nanoparticle (LNP) Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lipid Nanoparticle (LNP) Services Market CR5 and HHI
  11. 4.6.3 2025 Lipid Nanoparticle (LNP) Services Tier 1, Tier 2, and Tier 3
5 Lipid Nanoparticle (LNP) Services Market Size by Type
  1. 5.1 Global Lipid Nanoparticle (LNP) Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 5.3 Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Type (2021-2032)
6 Lipid Nanoparticle (LNP) Services Market Size by Application
  1. 6.1 Global Lipid Nanoparticle (LNP) Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  3. 6.3 Global Lipid Nanoparticle (LNP) Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 PreciGenome
  2. 7.1.1 PreciGenome Company Information
  3. 7.1.2 PreciGenome Business Overview
  4. 7.1.3 PreciGenome Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 PreciGenome Lipid Nanoparticle (LNP) Services Product Portfolio
  6. 7.1.5 PreciGenome Recent Developments
  7. 7.2 Creative Biolabs
  8. 7.2.1 Creative Biolabs Company Information
  9. 7.2.2 Creative Biolabs Business Overview
  10. 7.2.3 Creative Biolabs Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Creative Biolabs Lipid Nanoparticle (LNP) Services Product Portfolio
  12. 7.2.5 Creative Biolabs Recent Developments
  13. 7.3 Genscript
  14. 7.3.1 Genscript Company Information
  15. 7.3.2 Genscript Business Overview
  16. 7.3.3 Genscript Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Genscript Lipid Nanoparticle (LNP) Services Product Portfolio
  18. 7.3.5 Genscript Recent Developments
  19. 7.4 ReciBioPharm
  20. 7.4.1 ReciBioPharm Company Information
  21. 7.4.2 ReciBioPharm Business Overview
  22. 7.4.3 ReciBioPharm Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ReciBioPharm Lipid Nanoparticle (LNP) Services Product Portfolio
  24. 7.4.5 ReciBioPharm Recent Developments
  25. 7.5 CD Bioparticles
  26. 7.5.1 CD Bioparticles Company Information
  27. 7.5.2 CD Bioparticles Business Overview
  28. 7.5.3 CD Bioparticles Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CD Bioparticles Lipid Nanoparticle (LNP) Services Product Portfolio
  30. 7.5.5 CD Bioparticles Recent Developments
  31. 7.6 Vernal Biosciences
  32. 7.6.1 Vernal Biosciences Company Information
  33. 7.6.2 Vernal Biosciences Business Overview
  34. 7.6.3 Vernal Biosciences Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Vernal Biosciences Lipid Nanoparticle (LNP) Services Product Portfolio
  36. 7.6.5 Vernal Biosciences Recent Developments
  37. 7.7 Hzymes Biotech
  38. 7.7.1 Hzymes Biotech Company Information
  39. 7.7.2 Hzymes Biotech Business Overview
  40. 7.7.3 Hzymes Biotech Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hzymes Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  42. 7.7.5 Hzymes Biotech Recent Developments
  43. 7.8 LipExoGen
  44. 7.8.1 LipExoGen Company Information
  45. 7.8.2 LipExoGen Business Overview
  46. 7.8.3 LipExoGen Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LipExoGen Lipid Nanoparticle (LNP) Services Product Portfolio
  48. 7.8.5 LipExoGen Recent Developments
  49. 7.9 Evonik
  50. 7.9.1 Evonik Company Information
  51. 7.9.2 Evonik Business Overview
  52. 7.9.3 Evonik Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Evonik Lipid Nanoparticle (LNP) Services Product Portfolio
  54. 7.9.5 Evonik Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Merck Lipid Nanoparticle (LNP) Services Product Portfolio
  60. 7.10.5 Merck Recent Developments
  61. 7.11 Cayman
  62. 7.11.1 Cayman Company Information
  63. 7.11.2 Cayman Business Overview
  64. 7.11.3 Cayman Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cayman Lipid Nanoparticle (LNP) Services Product Portfolio
  66. 7.11.5 Cayman Recent Developments
  67. 7.12 Echelon
  68. 7.12.1 Echelon Company Information
  69. 7.12.2 Echelon Business Overview
  70. 7.12.3 Echelon Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Echelon Lipid Nanoparticle (LNP) Services Product Portfolio
  72. 7.12.5 Echelon Recent Developments
  73. 7.13 WuXi STA
  74. 7.13.1 WuXi STA Company Information
  75. 7.13.2 WuXi STA Business Overview
  76. 7.13.3 WuXi STA Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 WuXi STA Lipid Nanoparticle (LNP) Services Product Portfolio
  78. 7.13.5 WuXi STA Recent Developments
  79. 7.14 BOC Sciences
  80. 7.14.1 BOC Sciences Company Information
  81. 7.14.2 BOC Sciences Business Overview
  82. 7.14.3 BOC Sciences Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 BOC Sciences Lipid Nanoparticle (LNP) Services Product Portfolio
  84. 7.14.5 BOC Sciences Recent Developments
  85. 7.15 Carcell
  86. 7.15.1 Carcell Company Information
  87. 7.15.2 Carcell Business Overview
  88. 7.15.3 Carcell Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Carcell Lipid Nanoparticle (LNP) Services Product Portfolio
  90. 7.15.5 Carcell Recent Developments
  91. 7.16 Cambridge Bioscience
  92. 7.16.1 Cambridge Bioscience Company Information
  93. 7.16.2 Cambridge Bioscience Business Overview
  94. 7.16.3 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Cambridge Bioscience Lipid Nanoparticle (LNP) Services Product Portfolio
  96. 7.16.5 Cambridge Bioscience Recent Developments
  97. 7.17 FluidicLab
  98. 7.17.1 FluidicLab Company Information
  99. 7.17.2 FluidicLab Business Overview
  100. 7.17.3 FluidicLab Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 FluidicLab Lipid Nanoparticle (LNP) Services Product Portfolio
  102. 7.17.5 FluidicLab Recent Developments
  103. 7.18 Guangzhou Anernor Biotechnology
  104. 7.18.1 Guangzhou Anernor Biotechnology Company Information
  105. 7.18.2 Guangzhou Anernor Biotechnology Business Overview
  106. 7.18.3 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Guangzhou Anernor Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  108. 7.18.5 Guangzhou Anernor Biotechnology Recent Developments
  109. 7.19 Nanjing Yasmin Biotechnology
  110. 7.19.1 Nanjing Yasmin Biotechnology Company Information
  111. 7.19.2 Nanjing Yasmin Biotechnology Business Overview
  112. 7.19.3 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Nanjing Yasmin Biotechnology Lipid Nanoparticle (LNP) Services Product Portfolio
  114. 7.19.5 Nanjing Yasmin Biotechnology Recent Developments
  115. 7.20 vectorbuilder
  116. 7.20.1 vectorbuilder Company Information
  117. 7.20.2 vectorbuilder Business Overview
  118. 7.20.3 vectorbuilder Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 vectorbuilder Lipid Nanoparticle (LNP) Services Product Portfolio
  120. 7.20.5 vectorbuilder Recent Developments
  121. 7.21 Helix Biotech
  122. 7.21.1 Helix Biotech Company Information
  123. 7.21.2 Helix Biotech Business Overview
  124. 7.21.3 Helix Biotech Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Helix Biotech Lipid Nanoparticle (LNP) Services Product Portfolio
  126. 7.21.5 Helix Biotech Recent Developments
  127. 7.22 FUJIFILM Holdings
  128. 7.22.1 FUJIFILM Holdings Company Information
  129. 7.22.2 FUJIFILM Holdings Business Overview
  130. 7.22.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) Services Product Portfolio
  132. 7.22.5 FUJIFILM Holdings Recent Developments
  133. 7.23 Ascendia Pharmaceuticals
  134. 7.23.1 Ascendia Pharmaceuticals Company Information
  135. 7.23.2 Ascendia Pharmaceuticals Business Overview
  136. 7.23.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Services Product Portfolio
  138. 7.23.5 Ascendia Pharmaceuticals Recent Developments
  139. 7.24 Catalent
  140. 7.24.1 Catalent Company Information
  141. 7.24.2 Catalent Business Overview
  142. 7.24.3 Catalent Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Catalent Lipid Nanoparticle (LNP) Services Product Portfolio
  144. 7.24.5 Catalent Recent Developments
  145. 7.25 Polymun Scientific
  146. 7.25.1 Polymun Scientific Company Information
  147. 7.25.2 Polymun Scientific Business Overview
  148. 7.25.3 Polymun Scientific Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Polymun Scientific Lipid Nanoparticle (LNP) Services Product Portfolio
  150. 7.25.5 Polymun Scientific Recent Developments
  151. 7.26 Wacker
  152. 7.26.1 Wacker Company Information
  153. 7.26.2 Wacker Business Overview
  154. 7.26.3 Wacker Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Wacker Lipid Nanoparticle (LNP) Services Product Portfolio
  156. 7.26.5 Wacker Recent Developments
  157. 7.27 Corden Pharma
  158. 7.27.1 Corden Pharma Company Information
  159. 7.27.2 Corden Pharma Business Overview
  160. 7.27.3 Corden Pharma Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Corden Pharma Lipid Nanoparticle (LNP) Services Product Portfolio
  162. 7.27.5 Corden Pharma Recent Developments
  163. 7.28 Cytiva
  164. 7.28.1 Cytiva Company Information
  165. 7.28.2 Cytiva Business Overview
  166. 7.28.3 Cytiva Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Cytiva Lipid Nanoparticle (LNP) Services Product Portfolio
  168. 7.28.5 Cytiva Recent Developments
  169. 7.29 Croda International
  170. 7.29.1 Croda International Company Information
  171. 7.29.2 Croda International Business Overview
  172. 7.29.3 Croda International Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Croda International Lipid Nanoparticle (LNP) Services Product Portfolio
  174. 7.29.5 Croda International Recent Developments
  175. 7.30 Nippon Fine Chemical
  176. 7.30.1 Nippon Fine Chemical Company Information
  177. 7.30.2 Nippon Fine Chemical Business Overview
  178. 7.30.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) Services Product Portfolio
  180. 7.30.5 Nippon Fine Chemical Recent Developments
  181. 7.31 Patheon
  182. 7.31.1 Patheon Company Information
  183. 7.31.2 Patheon Business Overview
  184. 7.31.3 Patheon Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Patheon Lipid Nanoparticle (LNP) Services Product Portfolio
  186. 7.31.5 Patheon Recent Developments
  187. 7.32 Lonza
  188. 7.32.1 Lonza Company Information
  189. 7.32.2 Lonza Business Overview
  190. 7.32.3 Lonza Lipid Nanoparticle (LNP) Services Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Lonza Lipid Nanoparticle (LNP) Services Product Portfolio
  192. 7.32.5 Lonza Recent Developments
8 North America
  1. 8.1 North America Lipid Nanoparticle (LNP) Services Revenue (2021-2032)
  2. 8.2 North America Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032)
  5. 8.3 North America Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032)
  9. 8.5 North America Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Lipid Nanoparticle (LNP) Services Revenue by Country
  11. 8.6.1 North America Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Lipid Nanoparticle (LNP) Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lipid Nanoparticle (LNP) Services Revenue (2021-2032)
  2. 9.2 Europe Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032)
  5. 9.3 Europe Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032)
  9. 9.5 Europe Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lipid Nanoparticle (LNP) Services Revenue by Country
  11. 9.6.1 Europe Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lipid Nanoparticle (LNP) Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lipid Nanoparticle (LNP) Services Revenue (2021-2032)
  2. 10.2 China Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 10.2.1 China Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026)
  4. 10.2.2 China Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032)
  5. 10.3 China Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032)
  6. 10.4 China Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  7. 10.4.1 China Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026)
  8. 10.4.2 China Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032)
  9. 10.5 China Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lipid Nanoparticle (LNP) Services Revenue (2021-2032)
  2. 11.2 Asia Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032)
  5. 11.3 Asia Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032)
  9. 11.5 Asia Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lipid Nanoparticle (LNP) Services Revenue by Country
  11. 11.6.1 Asia Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lipid Nanoparticle (LNP) Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lipid Nanoparticle (LNP) Services Revenue (2021-2032)
  2. 12.2 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lipid Nanoparticle (LNP) Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lipid Nanoparticle (LNP) Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country
  11. 12.6.1 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lipid Nanoparticle (LNP) Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst